Pharmacologic prophylaxis for venous thromboembolism and 30-day outcomes among older patients hospitalized with heart failure: An analysis from the ADHERE national registry linked to medicare claims

Clinical Cardiology

Volumn 34, Issue 11, 2011, Pages 682-688

  Kociol, Robb D ^a   Hammill, Bradley G ^a   Hernandez, Adrian F ^a   Klaskala, Winslow ^b   Mills, Roger M ^c   Curtis, Lesley H ^a   Fonarow, Gregg C ^d  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^c JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^d UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

AGED; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HEART FAILURE; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; STROKE; VENOUS THROMBOEMBOLISM;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART FAILURE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HOSPITALIZATION; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; MEDICARE PART A; PATIENT DISCHARGE; PATIENT READMISSION; PROPENSITY SCORE; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 81555208928     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20986     Document Type: Article

References (27)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest. 2008; 133: 381S-453S. (Pubitemid 351894916)
2. Lip GY, Gibbs CR., Does heart failure confer a hypercoagulable state? Virchow's triad revisited. J Am CollCardiol. 1999; 33: 1424-1426.
3. Siddique RM, Siddique MI, Connors AF Jr, et al. Thirty-daycase-fatality rates for pulmonary embolism in the elderly. Arch Intern Med. 1996; 156: 2343-2347. (Pubitemid 26395548)
4. Kearon C., Natural history of venous thromboembolism. Circulation. 2003; 107: I22-I30. (Pubitemid 41289268)
5. Samama MM, Cohen AT, Darmon JY, et al. Prophylaxis in Medical Patients With Enoxaparin Study Group. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. N Engl J Med. 1999; 341: 793-800. (Pubitemid 29420474)
6. Michot M, Conen D, Holtz D, et al. Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: a randomized trial of prophylaxis with low-molecular weight heparin. Arthroscopy. 2002; 18: 257-263. (Pubitemid 36114580)
7. Turpie AG, Eriksson BI, Bauer KA, et al. New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. Chest. 2003; 124: 371S-378S. (Pubitemid 38005464)
8. Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. Lancet. 2003; 362: 1582-1583.
9. Alikhan R, Cohen AT, Combe S, et al. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis. 2003; 14: 341-346. (Pubitemid 36688187)
10. Turpie AG, Bauer KA, Eriksson BI, et al. Fondaparinuxvs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med. 2002; 162: 1833-1840.
11. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation. 2009; 119: e391-e479.
12. Dentali F, Douketis JD, Gianni M, et al. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med. 2007; 146: 278-288. (Pubitemid 351650614)
13. Adams KF Jr, Fonarow GC, Emerman CL, et al. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100 000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005; 149: 209-216. (Pubitemid 40348525)
14. Hammill BG, Hernandez AF, Peterson ED, et al. Linking inpatient clinical registry data to Medicare claims data using indirect identifiers. Am Heart J. 2009; 157: 995-1000.
15. Curtis LH, Hammill BG, Eisenstein EL, et al. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care. 2007;45(10 suppl 2): S103-S107.
16. Austin PC, Grootendorst P, Anderson GM., A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med. 2007; 26: 734-753. (Pubitemid 46206593)
17. Lin DY, Wei LJ., The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989; 84: 1074-1078.
18. Galvao M, Kalman J, DeMarco T, et al. Gender differences in in-hospital management and outcomes in patients with decompensated heart failure: analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Card Fail. 2006; 12: 100-107. (Pubitemid 43340150)
19. Kleber FX, Witt C, Vogel G, et al. Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease. Am Heart J. 2003; 145: 614-621. (Pubitemid 36403489)
20. Hernandez AF, Greiner MA, Fonarow GC, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010; 303: 1716-1722.
21. Heit JA., Venous thromboembolism: disease burden, outcomes and risk factors. J ThrombHaemost. 2005; 3: 1611-1617. (Pubitemid 41716546)
22. Jois-Bilowich P, Michota F, Bartholomew JR, et al. Venous thromboembolism prophylaxis in hospitalized heart failure patients. J Card Fail. 2008; 14: 127-132. (Pubitemid 351312885)
23. Piazza G, Goldhaber SZ., Physician alerts to prevent venous thromboembolism. J Thromb Thrombolysis. 2010; 30: 1-6.
24. Hull RD, Schellong SM, Tapson VF, et al. Extended-duration venous thromboembolism prophylaxis in acutely ill medical patients with recently reduced mobility: a randomized trial. Ann Intern Med. 2010; 153: 8-18.
25. Hull RD, Pineo GF, Stein PD, et al. Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med. 2001; 135: 858-869. (Pubitemid 33070682)
26. Eikelboom JW, Quinlan DJ, Douketis JD., Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet. 2001; 358: 9-15. (Pubitemid 32709732)
27. Kociol RD, Hammill BG, Fonarow GC, et al. Generalizability and longitudinal outcomes of a national heart failure clinical registry: Comparison of Acute Decompensated Heart Failure National Registry (ADHERE) and non-ADHERE Medicare beneficiaries. Am Heart J. 2010; 160: 885-889.